Alerts will be sent to your verified email
Verify Email
KKSHL
|
KK Shah Hospitals
|
Nidan Labs. & Health
|
Transgene Biotek
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.05 % | 4.89 % | -34.5 % |
|
5yr average Equity Multiplier
|
1.1 | 1.8 | 11.14 |
|
5yr Average Asset Turnover Ratio
|
0.47 | 0.32 | 0.0 |
|
5yr Avg Net Profit Margin
|
5.16 % | 5.91 % | -5919.21 % |
|
Price to Book
|
1.86 | 0.38 | 2.28 |
|
P/E
|
0.0 | 13.25 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
3.41 Days | -378.19 Days | 59.29 Days |
|
Inventory Days
|
0.0 | 3.89 Days | 166.26 Days |
|
Days Receivable
|
3.41 Days | 13.34 Days | 11.76 Days |
|
Days Payable
|
0.0 | 205.76 Days | 259.7 Days |
|
5yr Average Interest Coverage Ratio
|
-202.71 | 2.0 | -19.2 |
|
5yr Avg ROCE
|
2.76 % | 11.91 % | -3.86 % |
|
5yr Avg Operating Profit Margin
|
9.16 % | 30.14 % | -527.18 % |
|
5 yr average Debt to Equity
|
0.0 | 0.73 | 1.02 |
|
5yr CAGR Net Profit
|
n/a | -2.95 % | -42.08 % |
|
5yr Average Return on Assets
|
2.0 % | 2.0 % | -3.77 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
71.36 % | 57.04 % | 23.64 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -14.18 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
KK Shah Hospitals
|
Nidan Labs. & Health
|
Transgene Biotek
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|